Concord Clinical And Translational Resource Private Limited - Company Profile

It is a printing & publishing private limited company based in Bangalore South, Karnataka, India, established in 2017.
2017 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Concord Clinical And Translational Resource Private Limited

Concord Clinical And Translational Resource Private Limited, a active private limited company, was established on 16 August 2017 in Bangalore South, Karnataka, India. Engaging in recorded media within the printing & publishing sector, it holds CIN: U22300KA2017PTC105572. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Chandrashekar Hallikeri Basappa (Additional Director), Nagarajan Sukumar (Additional Director). Past directors included Nithyanand Perumal, Anand Prabhu Perumal. Its latest AGM occurred on 30 December 2022, with the balance sheet filed on 31 March 2022. It is based at # 733, 4Th Floor, 17Th B Main Road,, 6Th Block, Koramangala, Bangalore South, Karnataka, 560095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U22300KA2017PTC105572

  • Registration Number

    105572

  • Incorporation Date

    16 August 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 6 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** 190.00%
  • Profit Growth **** 72.65%
  • Ebitda **** 77.55%
  • Net Worth -72.34%
  • Total Assets -42.23%
Company report

Concord Clinical And Translational Resource Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Concord Clinical And Translational Resource Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Concord Clinical And Translational Resource Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandrashekar Hallikeri Basappa Additional Director 28 Nov 2023 Current
Nagarajan Sukumar Additional Director 04 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 04 Dec 2023 Past
Pramod Abcsdd Director 04 Dec 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Concord Clinical And Translational Resource.

Concord Clinical And Translational Resource Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 190% increase. The company also saw a substantial improvement in profitability, with a 72.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 72.34%.

Concord Clinical And Translational Resource revenue growth over time
Concord Clinical And Translational Resource profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 190.00%
*******
*******
*******
*******
Revenue from Operations
*******
 190.00%
*******
*******
*******
*******
Total Assets
*******
 -42.23%
*******
*******
*******
*******
Profit or Loss
*******
 72.65%
*******
*******
*******
*******
Net Worth
*******
 -72.34%
*******
*******
*******
*******
EBITDA
*******
 77.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Concord Clinical And Translational Resource?

Unlock access to Concord Clinical And Translational Resource's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Concord Clinical And Translational Resource?

Unlock and access historical data on people associated with Concord Clinical And Translational Resource, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Concord Clinical And Translational Resource, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Clinical And Translational Resource's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Concord Clinical And Translational Resource
Recent Activity within the Organization
  • Director Appointment

    Progress on Nagarajan Sukumar was appointed as a Additional Director was appointed as a Additional Director on 04 Dec 2023 & has been associated with this company since 2 years 2 months . was documented.

  • Director Appointment

    Progress on Chandrashekar Hallikeri Basappa was appointed as a Additional Director was appointed as a Additional Director on 28 Nov 2023 & has been associated with this company since 2 years 2 months . was documented.

  • Annual General Meeting

    The activity Concord Clinical And Translational Resource Private Limited last Annual general meeting of members was held on 30 Dec 2022 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Concord Clinical And Translational Resource Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was completed.

  • Company Incorporation

    Concord Clinical And Translational Resource Private Limited was registered on 16 Aug 2017 with Roc Bangalore & aged 8 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Concord Clinical And Translational Resource Private Limited?

The CIN of Concord Clinical And Translational Resource Private Limited is U22300KA2017PTC105572.

Where is Concord Clinical And Translational Resource Private Limited headquartered?

Concord Clinical And Translational Resource Private Limited is headquartered at # 733, 4Th Floor, 17Th B Main Road,, 6Th Block, Koramangala, Bangalore South, Karnataka, 560095.

When was Concord Clinical And Translational Resource Private Limited incorporated?

Concord Clinical And Translational Resource Private Limited was incorporated on 16 August 2017.

Who are the current directors of Concord Clinical And Translational Resource Private Limited?

The current directors of Concord Clinical And Translational Resource Private Limited are

What is the primary industry of Concord Clinical And Translational Resource Private Limited?

The primary industry of Concord Clinical And Translational Resource Private Limited is Printing & Publishing.

Is Concord Clinical And Translational Resource Private Limited a listed company?

Concord Clinical And Translational Resource Private Limited is unlisted.

What is the capital structure of Concord Clinical And Translational Resource Private Limited?

The authorized capital of Concord Clinical And Translational Resource Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Concord Clinical And Translational Resource Private Limited?

The compliance status of Concord Clinical And Translational Resource Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available